logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
V

Volker Heinemann

Ludwig-Maximilians-Universitat Munchen
H指数:91
被引数:4.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reproducibility of overall survival in metastatic colorectal cancer randomized trials using ARCAD-derived external control arms

转移性结直肠癌随机试验中基于ARCAD衍生外部对照臂的总体生存期可重复性

JNCI: Journal of the National Cancer Institute
IF0
2026-08-220
PRE
Morteza Raeisi, PhD; Thierry André, MD; Qian Shi, PhD; Takayuki Yoshino, MD, PhD; Richard Adams, MD; Chiara Cremolini, MD; Jeffrey A Meyerhardt, MD; Jeanne Tie, MD; Romain Cohen, MD, PhD; Jean-Baptiste Bachet, MD; Hideaki Bando, MD, PhD; Toshihiro Misumi, PhD; Carsten Bokemeyer, MD; Leonard B Saltz, MD; Miriam Koopman, MD; Volker Heinemann, MD; Marc Peeters, MD, PhD; Eric Van Cutsem, MD, PhD; Axel Grothey, MD; Benoist Chibaudel, MD; Aimery de Gramont, MD
Sex Differences in Efficacy and Toxicity of First-Line Treatment of Metastatic Colorectal Cancer: An Analysis of 18,041 Patients in the ARCAD CRC Database

转移性结直肠癌一线治疗的有效性和毒性的性别差异：ARCAD CRC数据库中18,041例患者的分析

European Journal of Cancer
IF7.1
2026-03-240
PRE
Anna D. Wagner; Morteza Raeisi; Manel Rakez; Robert D. Diasio; Ofer Margalit; John R. Zalcberg; Alan P. Venook; Jean-Yves Douillard; Heinz J. Lenz; Volker Heinemann; Richard M. Goldberg; Eric van Cutsem; Hans-Joachim Schmoll; Qian Shi; Thierry André; Aimery de Gramont
First-line treatment efficacy of anti-EGFR versus anti-VEGF antibodies in BRAFV600E-mutated metastatic colorectal cancer according to primary tumor sidedness: a pooled analysis of seven clinical trials performed in the first-line treatment of mCRC (German AIO Study Group)

抗EGFR抗体与抗VEGF抗体在BRAFV600E突变型转移性结直肠癌中根据原发肿瘤侧性的初始治疗疗效：一项在mCRC初始治疗中进行的七项临床试验的合并分析（德国AIO研究组）

European Journal of Cancer
IF7.1
2025-11-130
OAAI
Lena Weiss; Sebastian Stintzing; Dominik Paul Modest; Arndt Stahler; Ludwig Fischer von Weikersthal; Anke Reinacher-Schick; Thomas Decker; Victoria Probst; Kathrin Heinrich; Ingo Schwaner; Florian Kaiser; Rudolf Pihusch; Martin Fuchs; Swantje Held; Annabel Alig; Birgit Gruenberger; Gerald Werner Prager; David Tougeron; Julien Taieb; Volker Heinemann
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: an ARCAD database study

随着奥沙利铂为基础的化疗联合靶向药物，转移性结直肠癌的生存率随时间推移呈逐年改善：一项ARCAD数据库研究

European Journal of Cancer
IF7.1
2025-10-020
OAAI
Kazumasa Yamamoto; Hideaki Bando; Toshihiro Misumi; Tomomi Nishikawa; Masashi Wakabayashi; Kentaro Yamazaki; Yoshihiko Maehara; Eiji Oki; Leonard B Saltz; Jean-Yves Douillard; Cornelis JA Punt; Miriam Koopman; Eric Van Cutsem; Carsten Bokemeyer; Alan P Venook; Volker Heinemann; Chiara Cremolini; J. Randolph Hecht; Hans-Joachim Schmoll; Goro Nakayama; Heinz-Josef Lenz; Thierry Andre; Qian Shi; Aimery de Gramont; Kohei Shitara; Takayuki Yoshino
Outcomes for FOLFIRI plus bevacizumab or cetuximab in patients treated with oxaliplatin-based adjuvant therapy: a combined analysis of FIRE-3 and CALGB/SWOG 80405 (Alliance)

FOLFIRI联合贝伐珠单抗或西妥昔单抗在奥沙利铂为基础辅助治疗患者中的疗效：FIRE-3和CALGB/SWOG 80405 (Alliance)联合分析

European Journal of Cancer
IF7.1
2025-08-050
PRE
Francesca Battaglin; Bert H O'Neil; Sebastian Stintzing; Fang-Shu Ou; Tyler J Zemla; Donna Niedzwiecki; Federico Innocenti; Howard S Hochster; Ludwig Fischer von Weikersthal; Thomas Decker; Alexander Kiani; Ursula Vehling-Kaiser; Tobias Heintges; Christian Lerchenmüller; Lena Weiss; Kathrin Heinrich; Richard M Goldberg; Robert J Mayer; Richard L Schilsky; Charles D Blanke; Alan P Venook; Heinz-Josef Lenz; Volker Heinemann
Navigating rare cancer care: Patient-reported insights into patient journeys, time to diagnosis, decision-making and care coordination from a national cross-sectional study in Germany

导航罕见癌症护理：基于德国一项全国性横断面研究的患者报告见解，涉及患者就医历程、诊断时间、决策制定和护理协调

European Journal of Cancer
IF7.1
2025-07-050
PRE
Laura Oestreich; Friederike Mumm; Theresia Pichler; Myrto Boukovala; Vanessa Colonna; Dorit Di Gioia; Theres Fey; Volker Heinemann; Jana Hinneburg; Julia Lühnen; Maximilian Reichert; Michael Schoenberg; Anton Seitz; Karsten Spiekermann; Christine Spitzweg; Anke Steckelberg; Sebastian Theurich; C. Benedikt Westphalen; Sandro Zacher; Danmei Zhang; Michael von Bergwelt-Baildon
Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study

验证两种血浆多代谢物特征在胰腺导管腺癌风险或疑似患者中的价值（METAPAC）：一项前瞻性、多中心、研究者盲法、富集设计、IV期诊断研究

The Lancet Gastroenterology & Hepatology
IF0
2025-05-160
OA
Ujjwal M Mahajan; Bettina Oehrle; Elisabetta Goni; Oliver Strobel; Jörg Kaiser; Robert Grützmann; Jens Werner; Helmut Friess; Thomas M Gress; Thomas W Seufferlein; Waldemar Uhl; Uwe Will; John P Neoptolemos; Uwe A Wittel; Marlies Vornhülz; Simon Sirtl; Georg Beyer; Ivonne Regel; Stefan Boeck; Volker Heinemann; Fabian Frost; Antje Steveling; Henry Völzke; Astrid Petersmann; Matthias Nauck; Eckhard Weber; Beate Kamlage; Markus M Lerch; Julia Mayerle
A Phase Two, Single-Arm, Open-Label Study With Dostarlimab Monotherapy in Participants With Untreated Stage II/III dMMR/MSI-H Locally Advanced Rectal Cancer (AZUR-1)

一项针对未治疗的II期/III期dMMR/MSI-H局部晚期直肠癌患者的多塔利单抗单药治疗的二期、单臂、开放标签研究（AZUR-1）

Clinical Colorectal Cancer
IF3.2
2025-02-210
OAAI
Andrea Cercek; Jean-Baptiste Bachet; Jaume Capdevila; Naureen Starling; Eric Chen; Lisa Salvatore; Hideaki Bando; Sean O'Donnell; Lauren Harfst; Zsolt Szijgyarto; Volker Heinemann
Significant Alterations of Colorectal Cancer Care in the COVID-19 Pandemic With High Adherence to Quality Criteria in German Cancer Centers (CC) ‒ Data From the AIO CancerCOVID Consortium (AIO-YMO/KRK 520/ass)

在COVID-19大流行期间，德国癌症中心(CC)中结直肠癌护理的重大变化，并高度遵循质量标准——来自AIO CancerCOVID联盟（AIO-YMO/KRK 520/ass）的数据

Clinical Colorectal Cancer
IF3.2
2025-01-210
PRE
Céline Lugnier; Sarah Förster; Sabine Sommerlatte; Olaf Schoffer; Jens Christmann; Anna-Lena Kraeft; Tobias Terzer; Eleni Kourti; Oliver Overheu; Elena Schlageter; Ira Ekmekciu; Waldemar Uhl; Christoph Biermann; Lothar Müller; Marianne Sinn; Stefan Kasper-Virchow; Dominik Modest; Volker Heinemann; Jochen Schmitt; Jan Schildmann; Andrea Tannapfel; Anke Reinacher-Schick
MOUNTAINEER-03 phase III study design: first-line mFOLFOX6+tucatinib plus trastuzumab for HER2+metastatic colorectal cancer

MOUNTAINEER-03 III期研究设计: 一线mFOLFOX6图卡替尼联合曲妥珠单抗治疗HER2转移性结直肠癌

FUTURE ONCOLOGY
IF2.6
2024-12-261
OAAI
Strickler, John H.; Bekaii-Saab, Tanios; Cercek, Andrea; Heinemann, Volker; Nakamura, Yoshiaki; Raghav, Kanwal; Siena, Salvatore; Tabernero, Josep; Van Cutsem, Eric; Yoshino, Takayuki; Ramos, Jorge; Guan, Xuesong; Andre, Thierry
Towards routine proteome profiling of FFPE tissue: insights from a 1,220-case pan-cancer study

FFPE组织的常规蛋白质组分析: 来自1,220例泛癌症研究的见解

EMBO JOURNAL
IF8.3
2024-11-180
PRE
Tueshaus, Johanna; Eckert, Stephan; Schliemann, Marius; Zhou, Yuxiang; Pfeiffer, Pauline; Halves, Christiane; Fusco, Federico; Weigel, Johannes; Hoenikl, Lisa; Butenschoen, Vicki; Todorova, Rumyana; Rauert-Wunderlich, Hilka; The, Matthew; Rosenwald, Andreas; Heinemann, Volker; Holch, Julian; Steiger, Katja; Delbridge, Claire; Meyer, Bernhard; Weichert, Wilko; Mogler, Carolin; Kuhn, Peer-Hendrik; Kuster, Bernhard
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial
LANCET GASTROENTEROLOGY & HEPATOLOGY
IF38.6
2024-10-011
PRE
Dorman, Klara; Boeck, Stefan; Caca, Karel; Reichert, Maximilian; Ettrich, Thomas J.; Oettle, Helmut; Waidmann, Oliver; Modest, Dominik P.; Mueller, Lothar; Michl, Patrick; Kanzler, Stephan; Pink, Daniel; Reinacher-Schick, Anke; Geissler, Michael; Pelz, Henning; Kunzmann, Volker; Held, Swantje; Schichtl, Thomas; Heinemann, Volker; Kullmann, Frank

研究方向

暂未获取到该数据
S
Sebastian Stintzing
H 指数:49论文数:799被引数:1.1万
S
Stefan Boeck
H 指数:46论文数:265被引数:7,465
D
Dominik Paul Modest
H 指数:44论文数:436被引数:9,223
T
Thomas Kirchner
H 指数:75论文数:545被引数:2.2万
A
Andreas Jung
H 指数:70论文数:399被引数:2.1万
C
C. Benedikt Westphalen
H 指数:46论文数:297被引数:1.2万
L
Ludwig Fischer von Weikersthal
H 指数:41论文数:292被引数:9,564
S
Steffen Ormanns
H 指数:27论文数:178被引数:3,530
M
Michael Haas
H 指数:36论文数:184被引数:4,729
A
Alfredo Falcone
H 指数:89论文数:1,289被引数:4.1万